首页> 外文期刊>Neurosurgery >Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis--influence of clinical factors.
【24h】

Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis--influence of clinical factors.

机译:使用立体定向脑活检涂片制剂对术中诊断的验证:术中诊断与最终诊断-临床因素的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Despite improvements in imaging techniques, histopathological diagnosis is still an important tool in neuro-oncology. At Freiburg University Hospital in Germany, approximately 450 patients per year undergo a serial stereotactic biopsy to obtain a diagnosis. We analyzed the accuracy of intraoperative diagnosis for rapid establishment of treatment options. Furthermore, we wanted to find out whether the location and histopathology of the tumors as well as the age and sex of the patients affected accuracy. Because of the large number of biopsies performed per year, parameters could also be evaluated for rare cerebral lesions. METHODS: We retrospectively analyzed 5000 consecutive stereotactic brain biopsies from 4589 patients. The digital database comprises the intraoperative and final diagnoses, the location of the tumors, and the sex and age of the patients. Regression analysis was performed to identify parameters that had a significant impact on the results. RESULTS: Intraoperative diagnosis was correct in 90.3% of biopsies. This included complete correlation in 81.3% of the biopsies and partial correlation in 9% of the biopsies. In 5.1% of the biopsies, no correlation between the intraoperative and final diagnosis was obtained. In 4.6% of the biopsies, no diagnosis could be made during or after surgery. A high correlation was found for World Health Organization Type II astrocytomas and, with regression analysis, for World Health Organization Type I astrocytomas, glioblastomas, and metastases. CONCLUSION: Intraoperative diagnosis with stereotactic biopsy has high validity. Immediate treatment based on the intraoperative diagnosis can be justified (e.g., for metastases or glioblastomas). Stereotactic biopsy with an exact histopathological diagnosis is strongly recommended for planning adequate therapy for patients with unidentified brain lesions.
机译:目的:尽管影像技术有所改进,组织病理学诊断仍是神经肿瘤学的重要工具。在德国的弗赖堡大学医院,每年大约有450名患者接受了一系列的立体定向活检以得到诊断。我们分析了术中诊断的准确性,以快速建立治疗方案。此外,我们想了解肿瘤的位置和组织病理学以及患者的年龄和性别是否会影响准确性。由于每年进行大量活检,因此还可以评估罕见脑损伤的参数。方法:我们回顾性分析了4589例患者的5000例连续立体定向脑活检。数字数据库包括术中和最终诊断,肿瘤位置以及患者的性别和年龄。进行回归分析以确定对结果有重大影响的参数。结果:90.3%的活组织检查术中诊断正确。这包括在81.3%的活检组织中完全相关,在9%的活检组织中部分相关。在5.1%的活检中,术中诊断与最终诊断之间无相关性。在4.6%的活检中,在手术期间或之后无法进行诊断。发现与世界卫生组织II型星形细胞瘤以及通过回归分析与世界卫生组织I型星形细胞瘤,成胶质细胞瘤和转移密切相关。结论:立体定向活检术中诊断具有较高的有效性。可以根据术中诊断立即进行治疗(例如转移或成胶质细胞瘤)。强烈建议对立体定向活检进行准确的组织病理学诊断,以便为脑部未明的患者计划适当的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号